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Abstract
Background: Hyaluronic acid (HA) has been reported to have a positive effect on periodontal wound healing
following nonsurgical and surgical therapy. However, to date, a few basic in vitro studies have been reported to
investigating the potential of HA on human periodontal ligament (PDL) cell regeneration. Therefore, the aim of
this study was to investigate the effect of HA on PDL cell compatibility, proliferation, and differentiation in vitro.
Methods: Either non-cross-linked (HA_ncl) or cross-linked (HA_cl) HA was investigated. Human PDL cells were
seeded in 7 conditions as follows (1) Control tissue culture plastic (TCP) (2) dilution of HA_ncl (1:100), (3) dilution
of HA_ncl (1:10), 4) HA_ncl directly coated onto TCP, (5) dilution of HA_cl (1:100), 6) dilution of HA_cl (1:10) and
(7) HA_cl directly coated onto TCP. Samples were then investigated for cell viability using a live/dead assay, an
inflammatory reaction using real-time PCR and ELISA for MMP2, IL-1 and cell proliferation via an MTS assay.
Furthermore, the osteogenic potential of PDL cells was assessed by alkaline phosphatase(ALP) activity,
collagen1(COL1) and osteocalcin(OCN) immunostaining, alizarin red staining, and real-time PCR for genes
encoding Runx2, COL1, ALP, and OCN.
Results: Both HA_ncl and HA_cl showed high PDL cell viability (greater than 90%) irrespective of the culturing
conditions. Furthermore, no significant difference in both mRNA and protein levels of proinflammatory cytokines,
including MMP2 and IL-1 expression was observed. Both diluted HA_ncl and HA_cl significantly increased cell
numbers compared to the controlled TCP samples at 3 and 5 days. HA_ncl and HA_cl in standard cell growth
media significantly decreased ALP staining, COL1 immunostaining and down-regulated early osteogenic differentiation,
including Runx2, COL1, and OCN mRNA levels when compared to control samples. When osteogenic differentiation
medium (ODM) was added, interestingly, the expression of early osteogenic markers increased by demonstrating
higher levels of COL1 and ALP expression; especially in HA 1:10 diluted condition. Late stage osteogenic markers
remained inhibited.
Conclusions: Both non-cross-linked and cross-linked HA maintained high PDL cell viability, increased proliferation,
and early osteogenic differentiation. However, HA was consistently associated with a significant decrease in late
osteogenic differentiation of primary human PDL cells. Future in vitro and animal research is necessary to further
characterize the effect of HA on periodontal regeneration.
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Background
Hyaluronic acid (HA; also termed hyaluronan or hyalur-
onate) is an anionic, nonsulfated glycosaminoglycan and
considered an optimal biomaterial for tissue engineering,
given its broad expression in a connective tissue as well
as the significant role it plays during organogenesis, cell
migration and development in general [1–4]. Non-cross-
linked HA (HA_ncl) is biodegradable, biocompatible,
bioresorbable and also well known to improve tissue lubri-
cation in cartilage, guides cell growth and differentiation,
and speeds the healing and repair of chronic wounds [5].
Cross-linked HA (HA_cl) has also been utilized for tissue
engineering as a scaffold to further improve the overall
mechanical performance of the scaffolding material and ri-
gidity supporting the growth of various cells [6–9]. HA has
been widely used for patients with knee osteoarthritis due
to its ability to provide cartilage tissue integrity [10, 11].
Furthermore, in the oral maxillofacial area, HA injections
have been used as a treatment option to manage symptoms
of temporomandibular joint disorders [12, 13]. More
recently, HA has also been utilized for applications for
aesthetic purposes in the oral facial regions primarily to
reduce or to eliminate facial creases, interdental papilla
loss, and various other abnormalities [8, 14, 15].
Due to the growing use of HA in dentistry, HA has
also been hypothesized to have influences on periodontal
regeneration [16]. The management of periodontal defects
is mainly a result of the cooperative treatment of three
unique tissues which comprises the periodontium, the
periodontal ligament and the cementum and alveolar
bone. [6]. HA is an essential component of the periodontal
ligament matrix and has been shown to play various im-
portant roles in cell adhesion, migration and differenti-
ation mediated by various HA binding proteins and cell-
surface receptors such as CD44 [17]. This CD44 antigen is
expressed in periodontal tissues and HA-CD44 interaction
has been associated with periodontal ligament (PDL) cell
proliferation and mineralization activities [18].
Furthermore, other advantages of HA include its
anti-inflammatory activity promoting soft and hard
tissue healing response, which may be of significant
interest during periodontal regeneration [19]. Based on
these assumptions, exogenous HA has already been
tested in patients with chronic periodontitis in several
clinical studies reporting the beneficial effects of HA
on reducing bleeding of probing scores and probing
depths [2, 20–23]. However, to date, the in vitro effect
of HA on periodontal ligament activity has not been
clearly investigated.
Therefore, the aim of the present study was to investi-
gate the effects of HA_ncl and HA_cl on PDL cells by
stimulating cells under 3 different conditions of either
diluted samples with HA (co-existing at 2 concentrations
of 1:10 and 1:100 dilutions) or directly by precoating HA
onto tissue culture plastic. The PDL cells cultured with
either HA_ncl or HA_cl were assessed for cell viability
at 24 h, inflammatory cytokines expression at 1 day, cell
proliferation at 1, 3 and 5 days and osteogenic differenti-
ation marker expression at 7 days and 14 days.
Methods
Reagents and cell culture
HA was kindly provided by Regedent (Zürich, Switzerland)
utilizing 2 compositions of HA including non-cross-linked
native HA (hyaDENT, BioScience GmbH, Dümmer,
Germany) as well as a cross-linked HA (hyaDENT BG,
BioScience GmbH). HyaDENT (HA_ncl) contains a for-
mulation of 14.0 mg/mL of sodium hyaluronate (synthe-
sized by bacterial fermentation in Streptococcus [24],
non-cross-linked), and hyaDENT BG (HA_cl) contains
2.0 mg/mL of sodium hyaluronate and 16.0 mg/mL of
sodium hyaluronate cross-linked with butanediol digly-
cidyl ether (BDDE). The seven groups were tested as fol-
lows; (1) control tissue culture plastic (TCP) (2) dilution
of HA_ncl (1:100), (3) dilution of HA_ncl (1:10), (4)
HA_ncl directly coated onto TCP, (5) dilution of HA_cl
(1:100), (6) dilution of HA_cl (1:10) and (7) HA_cl dir-
ectly coated onto TCP based on our previous report
[25]. In short, HA was diluted in standard cell culture
growth medium consisting of DMEM (Gibco), 10% fetal
Bovine serum (FBS; Gibco) and 1% antibiotics (Gibco).
The 100 μl of HA were directly pre-coated in per 24-
culture well and then the amount of HA was adjusted
the same between 1:10 dilution and coating conditions
per well in the end post cell seeding.
The primary human PDL cells were obtained from the
middle third portion of each tooth extracted from three
healthy patients, with no signs of periodontal disease ex-
tracted for orthodontic as previously described [26, 27].
Using discarded tissue for research purposes was ap-
proved by the Ethical commission of the Canton Bern
without an IRB. All patients gave their consent. Briefly,
PDL tissues isolated from the center of the root surface
with a surgical scalpel were minced, transferred to TCP
with media changes every 2 or 3 days. The PDL cells
were detached from TCP using 0.25% EDTA-Trypsin
(Gibco, Life Technologies, Carlsbad, CA, USA) prior to
reaching confluency. Cells used for experimental seed-
ing were from passages 4–6. Cells were cultured in a
humidified atmosphere at 37 °C in the cell growth
medium. For in vitro experiments, cells were seeded
with HA contained within cell culture media at a dens-
ity of 10,000 cells in 24 well culture plates for cell
proliferation experiments and 50,000 cells per well in
24 well dishes for real-time PCR, ELISA, ALP assay,
immunostaining and alizarin red experiments. For ex-
periments lasting longer than 5 days, the medium was
replaced twice weekly.
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Cell viability
Primary human PDL cells were seeded in at a density of
12,500 cells / cm2 with (1) control TCP (2) dilution of
HA_ncl (1:100), (3) dilution of HA_ncl (1:10), (4)
HA_ncl directly coated, (5) dilution of HA_cl (1:100),
(6) dilution of HA_cl (1:10) and (7) HA_cl directly
coated, on chamber slides (Sigma, St. Louis, MO, USA).
At 1 day post cell seeding, cells were evaluated using a
live-dead staining assay according to the manufacturer’s
protocol (Enzo Life Sciences AG; Lausen, Switzerland)
as previously described [28]. Fluorescent images were
quantified with a fluorescent microscope (OLYMPUS
BX51, Tokyo, Japan).
Proliferation assay
PDL cells were seeded in 24-well plates at a density of
10,000 cells per well in a 24 well culture plate with the
same conditions, (1) control TCP (2) dilution of HA_ncl
(1:100), (3) dilution of HA_ncl (1:10), (4) HA_ncl dir-
ectly coated onto TCP, (5) dilution of HA_cl (1:100),
(6) dilution of HA_cl (1:10) and (7) HA_cl directly
coated onto TCP. Cells were quantified using a fluores-
cent MTS assay (Promega, Madison, WI, USA) at 1, 3
and 5 days for cell proliferation as previously described
[29]. At desired time points, cells were washed with
phosphate-buffered saline (PBS, pH = 7.4) and quan-
tified using a ELx808 Absorbance Reader (BIO-TEK,
Winooski, VT, USA).
Real-time PCR analysis
PDL cells were first cultured for 1 day with HA in
order to investigate its inflammatory marker expres-
sions, including matrix metalloproteinase-2 (MMP2)
and interleukin-1 (IL-1). Moreover, in order to investi-
gate the effects of HA on the osteogenic differentiation,
the cells were stimulated for 7 days within each con-
centration of HA with and without osteogenic differen-
tiation medium (ODM), which consisted of DMEM
supplemented with 10% FBS, 1% antibiotics, 50 μg/mL
ascorbic acid (Sigma) and 10 mM β-glycerophosphate
(Sigma) to promote osteogenic differentiation as previ-
ously described [30]. The RNA expressions of runt-related
transcription factor 2 (Runx2), collagen1a2 (COL1a2),
alkaline phosphatase (ALP), osteocalcin (OCN) in either
condition were measured. The total RNA was harvested
using High Pure RNA Isolation Kit (Roche, Basel,
Switzerland). Primer and probe sequences were fabri-
cated with primer sequences according to Table 1. A
Nanodrop 2000c (Thermo, Wilmington, DE, USA) was
used to quantify the total RNA levels. Real-time RT-PCR
was performed using FastStart Universal SYBR Green
Master mix (Roche) and quantified on an Applied Bio-
systems 7500 Real-Time PCR machine. The amplifica-
tion profile was 40 cycles at 95 °C for 15 s (annealing),
followed by 60 °C for 60 s (elongation). The ΔΔCt
method was used to calculate gene expression levels nor-
malized to the expression of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH).
Inflammatory cytokine quantification with ELISA
The supernatant culture media were collected at 1 and
3 days post cell seeding. MMP2 (DY902, range = 0.625–
20.00 ng/mL) and IL-1β/IL-F2 (DY201, range = 3.91–
250 pg/mL) were quantified using an ELISA assays
(R&D Systems, Minneapolis, MN, USA) according to
manufacturer’s protocol as previously described [31, 32].
Briefly, 100 μL of assay diluents and 100 μL of sample
were incubated for 2 h at room temperature in
antibody-precoated 96-well plates. Wells were washed
3 times with washing buffer, incubated for 2 h with
peroxidase-conjugated antibody solution, washed again,
followed by the addition of 100 μL of substrate solution
for 20 min and 50 μL of stopping solution for 20 min.
Absorbance was measured at 450 nm and 570 nm on
an ELx808 Absorbance Reader and subtract at 570 nm
from the readings at 450 nm.
ALP activity assay
PDL cells were stimulated within each concentration of
HA with and without ODM. At 7 days, cells were
quantified for alkaline phosphatase expression utilizing
a cell imaging system. Alkaline phosphatase activity was
monitored using a Leukocyte alkaline phosphatase kit
(procedure No. 86, Sigma) as previously described [33].
PDL cells were fixed by immersion in a citrate-acetone-
formaldehyde fixative solution for 5 min. The alkaline-
dye mixture was prepared by mixing 1 mL Sodium
Table 1 PCR primers for genes encoding MMP2, IL-1, Runx2,
ALP, COL1a2, OCN and GAPDH
Gene Primer Sequence
hMMP2 F ccccaaaacggacaaaga
hMMP2 R cttcagcacaaacaggttgc
hIL-1 F ggttgagtttaagccaatcca
hIL-1 R ggtgatgacctaggcttgatg
hRunx2 F tcttagaacaaattctgcccttt
hRunx2 R tgctttggtcttgaaatcaca
hCOL1a2 F cccagccaagaactggtatagg
hCOL1a2 R ggctgccagcattgatagtttc
hALP F gacctcctcggaagacactc
hALP R tgaagggcttcttgtctgtg
hOCN F agcaaaggtgcagcctttgt
hOCN R gcgcctgggtctcttcact
hGAPDH F agccacatcgctcagacac
hGAPDH R gcccaatacgaccaaatcc
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Nitrite Solution and 1 mL of a fast red violet alkaline
solution dissolved in 45 mL of distilled water and 1 mL
of Naphtol AS-Bl alkaline solution. Surfaces were then
placed in an alkaline dye mixture solution for 15 min
protected from light followed by rinsing in deionized
water. All images were captured on a Wild Heerbrugg
M400 ZOOM Makroskop (WILD HEERBRUGG, Heer-
brugg, Switzerland) at the same magnification and light
intensity and imported into Image J software (NIH,
Bethesda, MD, USA). Image segmentation (Threshold-
ing) was used to generate percent stained values for
each field of view.
Immunofluorescent staining
At 14 days post PDL cell seeding, the cells were fixed
with 4% formaldehyde for 10 min, followed by perme-
abilized within PBS containing 0.2% Triton X-100 and
blocked in PBS containing 1% bovine serum albumin
(BSA, Sigma) for 1 h. Subsequently, cells incubated over-
night at 4 °C either with a polyclonal rabbit to collagen
type I antibody (sc-28657, Santa Cruz, CA, USA) or a
polyclonal rabbit to osteocalcin antibody (sc-30044,
Santa Cruz) at a dilution of 1:75 in PBS containing 1%
BSA. After washing with PBS, cells were incubated for
1 h at 37 °C with TR-conjugated-goat-anti-rabbit anti-
bodies (sc-2780, Santa Cruz) (1:100) diluted in PBS
containing 1% BSA. Prior to viewing, samples were
mounted with Vectashield containing DAPI nuclear
staining (Vector, Burlingame, CA, USA). Images were
captured from each surface with an OLYMPUS BX51
fluorescence microscope. The optical density (OD) of
the fluorescent staining was quantified from 3 inde-
pendent experiments using Image J software.
Mineralization assay
Alizarin red staining was performed to determine the
presence of extracellular matrix mineralization. PDL
cells were stimulated for 14 days within each concentra-
tion of HA in ODM. After 14 days, cells were fixed in
96% ethanol for 15 min and stained with 0.2% alizarin
red solution (Alizarin Red S, Sigma) in water (pH 6.4) at
room temperature for 1 h as previously described [30].
All images were captured and the percentage of staining
was evaluated in the same manner as the ALP assay.
Statistical analysis
All experiments were performed in triplicate with three
independent experiments for each condition. Mean and
standard error (SE) were analyzed for statistical signifi-
cance using a one-way analysis of variance with Tukey
post hoc test (*, p values < 0.05 was considered signifi-
cant) by GraphPad Prism 6.0 software (GraphPad Soft-
ware, Inc., La Jolla, CA, USA).
Results
Cell viability and proliferation in response to HA
To investigate the biocompatibility of HA towards
human PDL cells, the alive / dead assay was utilized. It
was determined that both HA_ncl or HA_cl maintained
a high level of cell viability (over 90%) in the presence of
HA at various concentrations (Fig. 1). Moreover, the
mRNA expression of inflammatory cytokine genes en-
coding MMP2 and IL-1 of PDL cells treated with either
HA_ncl or HA_cl demonstrated little differences at
1 day post seeding when compared to control samples
(Fig. 2a, c). Inflammatory cytokine release of MMP and
IL-1 from PDL cells treated with either HA_ncl or
HA_cl was investigated at 1 day and 3 days post cell
seeding (Fig. 2b, d). There was no significant difference
Fig. 1 Cell viability staining of primary human primary PDL cells
exposed to control (TCP), non-cross-linked HA (HA_ncl) and cross-
linked HA (HA_cl) surfaces. For cell viability, Live-Dead staining was
done with viable cell appearing in green and dead cells in red. The
results from these experiments demonstrated that both HA_ncl and
HA_cl are highly biocompatible at dilutions of 1:100 and 1:10 as well
as pre-coated onto cell culture plastic
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between MMP2 and IL-1 release among both HA_ncl
and HA_cl treated groups as well as mRNA expression
(Fig. 2b, d). Thereafter, PDL cell proliferation was investi-
gated in response to HA_ncl and HA_cl at 1, 3 and 5 days
post seeding (Fig. 3). It was found that while cell numbers
were indifferent at 1 day post seeding (Fig. 3a), a signifi-
cant increase was observed at 3 and 5 days in either di-
luted condition for both HA_ncl and HA_cl (Fig. 3b, c).
Cell differentiation in response to HA
Thereafter, the primary human PDL cells were investi-
gated for their ability to differentiate when cultured with
HA_ncl and HA_cl (Figs. 4, 5, 6 and 7). The mRNA ex-
pression of osteogenic markers was compared by real-
time PCR for genes encoding Runx2, COL1a2, ALP and
OCN at 7 days (Fig. 4). All HA_ncl and HA_cl treat-
ments significantly downregulated Runx2, COL1a2, ALP
and OCN mRNA levels when compared with control
samples (Fig. 4a, c, e, g), in normal growth medium.
When ODM supplement was added to culture media, it
was found that no significant difference was observed in
the Runx2 mRNA expression (Fig. 4b), whereas both
HA_ncl and HA_cl in 1:10 diluted condition demon-
strated a 3-fold significant increase in COL1a2 mRNA
levels (Fig. 4d) and a 20-fold increase in ALP levels.
Nevertheless, the OCN mRNA expression was still sig-
nificantly downregulated in either 1:10 diluted or coated
conditions for both HA_ncl and HA_cl despite culture
with ODM at 7 days post cell seeding (Fig. 4h).
Moreover, it was generally found that HA_ncl signifi-
cantly decreased ALP staining. HA_cl treatment dem-
onstrated no significant changes in the ALP staining at
7 days likely as a result of the cross-linking HA (Fig. 5a).
Interestingly, when ODM was added to cell culture
media to promote osteogenic differentiation, HA_ncl at
a dilution of 1:10 significantly increased up to 5-fold
ALP staining when compared to all other treatment
modalities (Fig. 5b, depicted by **). In addition, both
HA_ncl and HA_cl coated samples demonstrated a sig-
nificant increase in ALP staining under ODM supplement
Fig. 2 Real-time PCR of PDL cells seeded with HA_ncl and HA_cl for genes encoding (a) matrix metalloproteinase-2 (MMP2), (c) Interleukin-1
(IL-1), at 1 days post seeding. Protein release at 1 and 3 days of (b) MMP2, (d) IL-1, (** denotes significantly higher than all other modalities
among HA treated groups, p < 0.05)
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when compared to control TCP at 7 days (Fig. 5b). There-
after, it was demonstrated that both HA_ncl and HA-cl
significantly decreased COL1 immunofluorescent staining
at 14 days post seeding (Fig. 6a, c) as well as mRNA ex-
pression via real-time PCR at 7 days (Fig. 4c).
Cells were further investigated by OCN immunostaining
and alizarin red staining when induced by HA_ncl and
HA_cl treatment (Figs. 6b, d, and 7). All HA_ncl and
HA_cl treatment significantly decreased OCN protein ex-
pression and alizarin red staining when compared to con-
trol samples as well as OCN mRNA expression (Fig. 4g, h).
Discussion
In the present study, the effect of high molecular weight
(HMW) HA_ncl and HA_cl were evaluated on in vitro
periodontal ligament cell behavior. It was first found that
both HA_ncl and HA_cl did not elucidate PDL cell
apoptosis even at high concentrations (Fig. 1). Both
compositions of HA were shown to be biocompatible on
PDL cells without any noticeable differences between
their in vitro conditions (diluted in culture media versus
pre-coated onto TCP).
We then sought to investigate the inflammatory re-
sponse of HA on PDL cells. It has previously been shown
that low molecular weight (LMW, 100–500 kDa) HA, but
not the native HMW HA molecules (~4,000 kDa), stimu-
lated inflammatory cells [34]. Nakatani et al. reported that
the expression of MMP-1 in cultured human PDL cells
was enhanced by the treatment with HA-oligo through
p38MAPK signaling pathway, suggesting that the degrad-
ation of the periodontal tissues under pathologic conditions
may involve MMP-1 induction by HA-oligo [35]. On the
other hand, the majority of products used in connection
with periodontal therapy contain HMW HA [8]. The
mechanism of anti-inflammatory effects of HMW HA has
been widely investigated previously due to the pronounced
impact and desire for treatment modalities in the field of
osteoarthritis and periodontitis. HA has been shown to
modulate inflammation in articular chondrocytes and syno-
viocytes, due to the specific inhibition of MMPs [19, 36]
and down-regulation of TNF-α, IL-8, and inducible nitric
oxide synthase [37]. In the present study, HMW HA and
HA_cl did not affect the mRNA expressions of inflamma-
tory cytokines, including MMP-2 and IL-1 at 1 day post
seeding in healthy PDL cells (Fig. 2). The present study was
assessed only in utilizing healthy human PDL cells, whereas
in the presence of inflammation, HMW HA within these
tissues is reportedly broken down to LMW HA by reactive
oxygen species or by bacterial hyaluronidase [8, 38–40].
Therefore, these combined results suggest that although
HA demonstrated the little influence on the inflammation
in the current study utilizing healthy PDL cells, a more
pronounced effect could be observed in diseased tissues
due to gingival tissue inflammation in periodontitis.
Fig. 3 Proliferation assay of PDL cells seeded with HA_ncl and
HA_cl at (a) 1, (b) 3 and (c) 5 days post seeding. It was found that
both HA and HA_cl at dilutions of 1:100 and 1:10 significantly
increased cell numbers at 3 days and 5 days post seeding when
compared to control samples († denotes significantly higher than
control, p < 0.05)
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Fig. 4 (See legend on next page.)
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Thereafter, the effects of HA demonstrated an increase
in PDL cell proliferation (Fig. 3). During the granulation
phase of periodontal tissue repair, HA has been shown
to be a key protein highly expressed in various tissues
responsible for promoting cell proliferation, migration,
and granulation tissue organization [19]. In non-
mineralized tissues, HA is transiently elevated during
the formation of tissue repair and helps with the re-
establishment of the epithelium [38]. In our study,
both 1:100 and 1:10 dilution of HA_ncl, as well as
HA_cl, promoted cell proliferation at 3 and 5 days post
PDL cell seeding (Fig. 3). It was previously shown by
Takeda et al. in the same manner that HMW HA en-
hanced cell adhesion and proliferation of human peri-
odontal ligament cells [9]. In our study, both diluted
HA compositions and pre-coated HA promoted PDL
cell proliferation, which suggests a positive effect for
periodontal tissue regeneration.
The effect of HMW HA on cell differentiation has
however had controversial findings. To date, most
studies reported that cell differentiation was increased
by low-MW HA [16, 41–43]. Huang et al. [41] reported
an osteogenic cell behavior of HMW HA in a
concentration-dependent manner on rat mesenchymal
stem cells. Moreover, it was demonstrated that sulfated
HMW HA could enhance the osteogenic differentiation
of human mesenchymal stem cells [44]. On the other
hand, studies have also shown that cell differentiation
was not affected by HMW HA [16, 45–48]. For ex-
ample, Kaneko et al. demonstrated that HA inhibited
BMP-induced osteoblastic differentiation through the
CD44 receptor in osteoblasts [45]. Noteworthy, in a
pure bone defect model, it was demonstrated that HA-
gelatin hydrogels loaded into biphasic calcium phos-
phate (BCP) ceramics in rabbit femurs promoted the
new bone formation and collagen mineralization [46].
HA gel has further been shown to accelerate the heal-
ing process in the tooth sockets of rats, stimulating the
expression of osteogenic proteins such as bone mor-
phogenetic protein (BMP)-2 and osteopontin (OPN) in
vivo [47]. On the other hand, Atilgan et al. reported
that the demineralized bone matrix (DBM) + tricalcium
phosphate + HA combination showed more new bone
formation without HA [48]. Therefore, there remains
great interest to determine what may be causing the
reported variability in the literature.
In the present study, the expression of osteogenic
markers stimulated by HA_ncl and HA_cl was investi-
gated with and without ODM. Both HA_ncl and HA_cl
down-regulated Runx2, COL1a2 and OCN mRNA
levels, suggesting that HA treatment of PDL cells in-
hibits osteogenesis in a regular cell culture medium
(Fig. 4). Moreover, it was observed that HA significantly
decreased ALP activity at 7 days, COL1 and OCN
(See figure on previous page.)
Fig. 4 Real-time PCR of PDL cells seeded with HA_ncl and HA_cl treatment for genes encoding (a, b) Runx2, (c, d) Collagen 1 alpha 2 (COL1a2),
(e, f) alkaline phosphatase (ALP) and (g, h) osteocalcin (OCN) at 7 days post seeding. Cells were treated (a, c, e, g) in regular growth medium or
(b, d, f, h) with ODM. (* denotes significant difference, p < 0.05; # denotes significantly lower than control, p < 0.05; † denotes significantly higher
than control, p < 0.05; ** denotes significantly higher than all other treatment modalities, p < 0.05)
Fig. 5 Alkaline phosphatase staining of PDL cells treated by HA_ncl and HA_cl (a) in growth medium or (b) within ODM at 7 days post seeding.
Both HA_ncl and HA_cl significantly decreased ALP staining without ODM while with ODM both HA_ncl and HA_cl significantly increased ALP
staining when compared to control samples (* denotes significant difference, p < 0.05; # denotes significantly lower than control, p < 0.05; † denotes
significantly higher than control, p < 0.05; ** denotes significantly higher than all other treatment modalities, p < 0.05)
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immunofluorescent staining at 14 days when compared to
control samples (Figs. 5a, 6). Interestingly, however, when
ODM was added to promote osteoblast differentiation, it
was found that both HA_ncl or HA_cl in 1:10 diluted con-
dition demonstrated a 3-fold and 20-fold increase in
COL1a2 and ALP mRNA levels respectively in ODM
(Fig. 4d, f ). Moreover, HA_ncl at a dilution of 1:10 demon-
strated a 5-fold significant increase in ALP staining
compared to control samples in the presence of ODM
(Fig. 5b). Therefore, it may be concluded that if granted
the right culture conditions, the HA may be used to pro-
mote early osteogenic differentiation. Interestingly, how-
ever, was the finding that irrespective of the addition of
ODM, both HA compositions consistently down-regulated
late osteoblast differentiation as assessed by OCN mRNA
expression as well as alizarin red staining (Fig. 7).
Fig. 6 Immunofluorescent COL1 staining and OCN staining at 14 days post cell seeding with HA_ncl and HA_cl. (a) The merged images of
immunofluorescent detection of COL1 (red) and DAPI (blue). (b) The merged images of immunofluorescent detection of OCN (red) and DAPI
(blue). (c, d) Quantified data of (c) COL1 and (d) OCN immunostaining at 14 days (# denotes significantly lower than control, p < 0.05)
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For periodontal regeneration, HMW HA has previ-
ously been investigated in a dog intrabony defect model
and neither significant periodontal tissue nor bone tissue
regeneration was observed [9]. Interestingly, in another
canine model, Kim et al. reported that HA improved
wound healing and bone formation of hemisection per-
formed extraction sockets with communication of the
periodontal lesion [49]. The effect of HMW-HA on peri-
odontal regeneration remains somewhat controversial,
however, its contradiction might be explained due to the
variety of HA molecular weight, modification methods,
concentration, existence of inflammation and also cell
types. It may be that HA requires an osteoconductive
matrix during periodontal regeneration to improve the
osteogenic phase of PDL regeneration, however, this
hypothesis certainly requires further investigation.
Conclusion
Both HA_ncl and HA_cl were shown to be extremely
biocompatible and at both concentrations were associated
with a significant increase in PDL cell numbers. The early
osteogenic differentiation markers such as Runx2, COL1
and ALP were significantly downregulated in standard cell
growth media. Interestingly, with the addition of ODM,
the expression of early osteogenic markers was shown to
significantly increase COL1 and ALP levels, especially at
higher concentration (1:10) utilizing both HA_ncl and
HA_cl diluted condition. Nevertheless, the late stage
osteogenic marker such as OCN as well as calcium for-
mation was inhibited regardless of the ODM addition.
Future in vitro models including in inflammatory condi-
tions, as well as animal research, are necessary to further
characterize the optimal uses as well as delivery systems
of HA for improved clinical use.
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